CSIMarket
 


X4 Pharmaceuticals Inc  (XFOR)
Other Ticker:  
 
 

XFOR's Free Cash Flow Growth by Quarter and Year

X4 Pharmaceuticals Inc's Free Cash Flow results by quarter and year




XFOR Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -19.09 -19.05 -17.50
III Quarter September -20.83 -19.31 -14.21 -14.33
II Quarter June -21.43 -18.47 -19.20 -11.46
I Quarter March 50.59 -20.23 -18.44 -15.53
FY   8.33 -77.10 -70.90 -58.82



XFOR Free Cash Flow third quarter 2023 Y/Y Growth Comment
X4 Pharmaceuticals Inc in the third quarter 2023 recorded free cash outflow of $ -20.83 millions.

According to the results reported in the third quarter 2023, X4 Pharmaceuticals Inc achieved the best Free Cash Flow growth in Biotechnology & Pharmaceuticals industry. While X4 Pharmaceuticals Inc' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2023.




XFOR Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
X4 Pharmaceuticals Inc's third quarter 2023 Free Cash Flow $ -20.83 millions XFOR's Income Statement
X4 Pharmaceuticals Inc's third quarter 2022 Free Cash Flow $ -19.31 millions Quarterly XFOR's Income Statement
New: More XFOR's historic Free Cash Flow Growth >>


XFOR Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

X4 Pharmaceuticals Inc's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


XFOR's III. Quarter Q/Q Free Cash Flow Comment
Even if X4 Pharmaceuticals Inc in the III. Quarter 2023 revealed free cash outflow of $ -20.83 millions, it should be point out, that this are slight up side relative to the -21.43 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry X4 Pharmaceuticals Inc achieved highest sequential Free Cash Flow growth. While X4 Pharmaceuticals Inc's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


XFOR's III. Quarter Q/Q Free Cash Flow Comment
Even if X4 Pharmaceuticals Inc in the III. Quarter 2023 showed free cash outflow of $ -20.83 millions, management mentioned, that this show slight up side compare to the -21.43 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry X4 Pharmaceuticals Inc achieved highest sequential Free Cash Flow growth. While X4 Pharmaceuticals Inc's Free Cash Flow growth quarter on quarter, overall rank is .


X4 Pharmaceuticals Inc's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Free Cash Flow 12 Months Ending $ -10.76 $ -9.23 $ -6.28 $ -77.00 $ -76.98
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment


X4 Pharmaceuticals Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment


X4 Pharmaceuticals Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
XFOR's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for XFOR's Competitors
Free Cash Flow Growth for X4 Pharmaceuticals Inc's Suppliers
Free Cash Flow Growth for XFOR's Customers

You may also want to know
XFOR's Annual Growth Rates XFOR's Profitability Ratios XFOR's Asset Turnover Ratio XFOR's Dividend Growth
XFOR's Roe XFOR's Valuation Ratios XFOR's Financial Strength Ratios XFOR's Dividend Payout Ratio
XFOR's Roa XFOR's Inventory Turnover Ratio XFOR's Growth Rates XFOR's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2023
Catalyst Pharmaceuticals Inc 9.27%$ 9.266 millions
Prestige Consumer Healthcare Inc 8.55%$ 8.551 millions
Align Technology inc 7.78%$ 7.777 millions
Mettler toledo International Inc 7.69%$ 7.686 millions
Exelixis Inc 6.63%$ 6.628 millions
Royalty Pharma Plc6.44%$ 6.439 millions
Bio techne Corp5.89%$ 5.888 millions
Medpace Holdings Inc 5.43%$ 5.433 millions
Elanco Animal Health Inc4.76%$ 4.762 millions
Pacira Biosciences inc 4.18%$ 4.182 millions
Yunhong Green Cti Ltd 3.96%$ 3.959 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com